Dr. Smith has extensive history serving in executive and board level capacities for various medical enterprises and healthcare-based entities. She founded and has served as Chairman of the Board and President of The Stem for Life Foundation (SFLF) since its inception, an organization which is devoted to fostering global awareness of the potential for regenerative medicine to treat and cure a range of deadly diseases and debilitating medical conditions. She is expanding SFLF's mission further under the Cura Foundation where she serves as President and Chairman. Their efforts are focused on bringing resources to fund cell therapy clinical trials and assist in accelerating enrollment and completion. Dr. Smith also serves as Chairman for MYnd Analytics, Inc., a predictive analytics company that developed a decision support system to help physicians reduce trial and error treatment in mental health. Recently Hooper Holmes and MYnd Analytics announced a strategic partnership whereby the Hooper Holmes national network of health professionals will provide on-site or in-home EEG services for MYnd Analytics nationally.About Hooper Holmes Hooper Holmes mobilizes a national network of health professionals to provide on-site health screenings, laboratory testing, risk assessment and sample collection services to wellness and disease management companies, employers and brokers, government organizations and academic institutions nationwide. Under the Accountable Health Solutions brand, the Company combines smart technology, healthcare and behavior change expertise to offer comprehensive health and wellness programs that improve health, increase efficiencies and reduce healthcare delivery costs. www.hooperholmes.com This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intends," "plan," and "will" or, in each case, their negative, and other variations or comparable terminology. These forward-looking statements include all statements other than historical facts. Any forward-looking statement made by management during this call is not a guarantee of future performance, and actual results may differ materially from those expressed in or suggested by the forward-looking statements, as a result of various factors, including, without limitation the factors discussed in the "Risk Factors" section of the company's Annual Report on Form 10-K for the year ended December 31, 2016, as the same may be updated from time-to-time in subsequent filings with the Securities and Exchange Commission. Any forward-looking statement made by management on this call speaks only as of the date hereof, and the Company has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. In addition, management uses the non-GAAP performance measures EBITDA and Adjusted EBITDA in this press release.
For further information:Hooper HolmesHenry E. DuboisPresident and CEO(913) 764-1045Investors: Andrew BergerS.M. Berger & Company(216) 464-6400Investors: Scott GordonCORE IR(516) 222-2560